A leader of neuroimaging and addiction science at Mount Sinai has discovered the impairment of a brain circuit pathway as a key driver in human drug addiction, extending previous findings in animal models. These findings hold potential for targeting a previously unexplored circuit in the pathophysiology of addiction in humans.